Urotensin Ⅱ receptor antagonist reduces hepatic resistance and portal pressure through enhanced eNOS-dependent HSC vasodilatation in CCl4-induced cirrhotic rats

所属期刊栏目：13

资助基金：This study was supported by the National Natural Science Foundation of China81170408 to Diangang Liu;the Wang Baoen Liver Fibrosis Research Foundation of the China Hepatitis Prevention Foundation20120124 to Diangang Liu;the China Postdoctoral Science Foundation2012M510094 to Diangang Liu

在线出版日期：2019-07-04（万方平台首次上网日期，不代表论文的发表时间）

页数：共11页

页码：398-408